Gifting Made Simple
Give the Gift of ChoiceClick below to purchase a Prairie Mall eGift Card that can be used at participating retailers at Prairie Mall.Buy Gift CardHome
Making the Case for MTET: Where Miracles Become Standard In Oncology
Coles
Loading Inventory...
Making the Case for MTET: Where Miracles Become Standard In Oncology in Grande Prairie, AB
Current price: $300.21
Coles
Making the Case for MTET: Where Miracles Become Standard In Oncology in Grande Prairie, AB
Current price: $300.21
Loading Inventory...
Size: Hardcover
*Product information and pricing may vary - to confirm current pricing, availability, shipping, and return information please contact Coles. In the event of a pricing discrepancy, the retailer's price will apply.
Millions of cancer cases are diagnosed yearly. While a cure has yet to be discovered, one of the most promising new treatments is Multi-Targeted Epigenetic Therapy, or MTET.
In Making the Case for MTET , world-renowned oncology expert Dr. Mohammad A. Nezami introduces his revolutionary method of treating patients with advanced cancer by using a careful combination of drugs and genomic sequencing. For some patients with stage four cancer, MTET has been a lifesaving intervention. Dr. Nezami presents 300 case studies of patients with advanced cancer that he treated over ten years of longitudinal tracking with MTET. Through meticulously documented data, lab reports, and full-color photographs to detailed genomic information, Dr. Nezami makes a compelling case for furthering MTET research and focusing on patient-centric care.
Millions of cancer cases are diagnosed yearly. While a cure has yet to be discovered, one of the most promising new treatments is Multi-Targeted Epigenetic Therapy, or MTET.
In Making the Case for MTET , world-renowned oncology expert Dr. Mohammad A. Nezami introduces his revolutionary method of treating patients with advanced cancer by using a careful combination of drugs and genomic sequencing. For some patients with stage four cancer, MTET has been a lifesaving intervention. Dr. Nezami presents 300 case studies of patients with advanced cancer that he treated over ten years of longitudinal tracking with MTET. Through meticulously documented data, lab reports, and full-color photographs to detailed genomic information, Dr. Nezami makes a compelling case for furthering MTET research and focusing on patient-centric care.
You May Also Like
Find at Prairie Mall in Grande Prairie, AB
Visit at Prairie Mall in Grande Prairie, AB